Jones Day (Washington DC)

Larissa Bergin

Jones Day (Washington DC)
Lawyer (Associate)

Larissa Bergin’s practice addresses the antitrust concerns arising from M&A matters, joint ventures, federal investigations, and commercial practices. She has overseen the antitrust aspects of corporate M&A, including due diligence, risk-shift negotiations, Hart-Scott-Rodino (HSR) filings, Second Requests, investigational hearings, integration planning, and consent decrees with federal agencies. She works with clients in a variety of industries, including the technology, health care, retail, and pharmaceutical sectors. Many of Larissa’s clients have international reach, and she has been involved in matters that require advocacy before governments throughout Asia, the EU, and North America.

Distinctions

Linked authors

Jones Day (Sydney)
Jones Day (Mexico)
Jones Day (Brussels)
Jones Day (New York)
Jones Day (Washington DC)

Articles

715 Bulletin

Sarah A. Geers, Jonathan Berman, Larissa Bergin, Rosanna McCalips, Ryan C. Thomas The US Court of Appeals for the Fifth Circuit rules that showing the reverse payment settlement eliminated the possibility of an earlier generic entry is enough to infer anticompetitive effect (Endo / Impax)

165

In Short The Background: In the Supreme Court’s landmark 2013 decision in FTC v. Actavis, the Court determined that large payments by branded drugmakers to potential generic entrants to settle patent disputes could be anticompetitive. It instructed district courts to apply the "rule of reason" (...)

Jonathan Berman, Rosanna McCalips, Julia McEvoy, Larissa Bergin The US Congress implements a law requiring drug manufacturers to disclose biologic patent settlement agreements to antitrust Authorities

159

New Law Requires Disclosure of Biologic Patent Settlement Agreements to Antitrust Authorities* Last week, the Patient Right to Know Drug Prices Act ("Act") became law. The Act requires pharmaceutical companies to disclose to antitrust agencies agreements between biologic and biosimilar (...)

Send a message